tiprankstipranks
Cortexyme Inc (CRTX)
NASDAQ:CRTX
US Market

Cortexyme (CRTX) Stock News & Sentiment

0 Followers
Cortexyme Develops 3CLpro Inhibitor to Treat COVID-19 Infection
PremiumMarket News
Cortexyme Develops 3CLpro Inhibitor to Treat COVID-19 Infection
3y ago
Clinical stage biopharmaceutical company Cortexyme, Inc. (CRTX) recently announced the selection of a lead 3CLpro inhibitor (COR803) to treat coronavirus infections. Following the news, shares of the company declined marginally ...Read more
The Bottom Is in for These 2 Stocks? Analysts Say ‘Buy’
PremiumIdeas & Insights
The Bottom Is in for These 2 Stocks? Analysts Say ‘Buy’
3y ago
2 Biotech Stocks That Could Double in 2021; Canaccord Says ‘Buy’
PremiumIdeas & Insights
2 Biotech Stocks That Could Double in 2021; Canaccord Says ‘Buy’
3y ago

News Score - Last 7 Days

Neutral
CRTX
Sector Average
Media Buzz
This Week4 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRTX’s Media Buzz Sentiment?
4 articles about CRTX were published this week. In an average week, 1.25 articles are published.
    What is CRTX’s weekly average amount of articles?
    In an average week, 1.25 articles about CRTX are published.
      What is CRTX’s News Sentiment?
      50% of articles about CRTX were positive this week, compared to its sector average of 60%.
        Healthcare Stocks that are Trending in the News
        GMDAGamida Cell
        BHCBausch Health Companies
        SAVACassava Sciences
        OBSVObsEva SA
        ABCAmerisourceBergen
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis